{"id":"W2548392800","doi":"10.1097/01.cot.0000471143.28320.70","title":"3 Questions on... Why ‘Whatʼs Old Is New’ in CML with Carlo Gambacorti-Passerini, MD","year":2015,"lang":"en","type":"article","venue":"Oncology Times","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Imatinib; Bosutinib; Dasatinib; Medicine; Imatinib mesylate; Ponatinib; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006809715,0.0007653211,0.00122186,0.001123604,0.003419869,0.006397741,0.002048051,0.01936851,0.01665049],"category_scores_gemma":[0.04755502,0.0005447961,0.001591881,0.0007203913,0.005307199,0.008678866,0.001955363,0.02868399,0.008945839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003563579,"about_ca_system_score_gemma":0.005666869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005465735,"about_ca_topic_score_gemma":0.008869238,"domain_scores_codex":[0.9950585,0.001768583,0.0004625552,0.0007080868,0.001428205,0.0005741637],"domain_scores_gemma":[0.978231,0.01136871,0.001088259,0.0004436509,0.005884675,0.00298363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001074806,0.000005391591,0.0001182877,0.0000552023,0.000006411092,0.0001024903,0.0001068493,0.000009578598,0.0000218093,0.001125273,0.993204,0.005233991],"study_design_scores_gemma":[0.00003245927,0.00002185602,0.0003312955,0.0006911248,0.00002244887,0.0007635301,0.0004976564,0.00005314278,0.00006602023,0.00440741,0.9930804,0.00003274038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001091964,0.01092326,0.0001074933,0.8907053,0.09529168,0.000007224919,0.00004388611,0.00003281662,0.002779154],"genre_scores_gemma":[0.002636375,0.00965244,0.0001677904,0.8203949,0.1609373,0.00002018196,0.00003790579,0.0000616437,0.006091438],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01936851,"threshold_uncertainty_score":0.05570149,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04563207950593276,"score_gpt":0.3602349910445021,"score_spread":0.3146029115385693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}